Data Bridge Market Research projects growth in ontogenetic and vascular closure device markets

Data Bridge Market Research released two separate forecast reports covering the global ontogenetic market and the vascular closure device market. The ontogenetic market was valued at USD 1.91 billion in 2024 and is projected to reach USD 2.69 billion by 2032, representing a compound annual growth rate of 4.32 %. The report cites expanding research in genetics, personalized medicine, and the integration of AI as key drivers.

The vascular closure device market was valued at USD 1.94 billion in 2024 and is expected to grow to USD 3.16 billion by 2032, with a CAGR of 6.33 %. Growth is attributed to the rising prevalence of cardiovascular disease, increasing demand for minimally invasive procedures, and technological advancements in device design. Both reports list major industry players, including Illumina, Thermo Fisher Scientific, Medtronic, Abbott and others, and highlight ongoing innovation and strategic partnerships within the sectors.